🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this Phase II study will be to investigate the antiangiogeni...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2013-01
Trial ID
NCT01749956
Treatments Being Tested
This phase I trial studies the side effects and best dose of ziv-aflibercep...
Status
Active Not Recruiting
Location
Moffitt Cancer Center-International Plaza
Start Date
2015-04-08
Trial ID
NCT02298959
This randomized controlled trial compares two techniques for eyelid retract...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07481500
Treatments Being Tested
This Phase 3 study will evaluate the efficacy, durability, and safety of KS...
Status
Terminated
Location
UCSD Jacobs Retina Center
Start Date
2020-09-30
Trial ID
NCT04611152
Treatments Being Tested
Generally, DM is caused by insufficient insulin secretion in the body; howe...
Status
Not Yet Recruiting
Location
faculty of medicine, Tanta University
Start Date
2025-10-19
Trial ID
NCT06879301
Treatments Being Tested
This Phase 3 study will evaluate the efficacy, durability, and safety of KS...
Status
Completed
Location
Northwest Arkansas Retina Associates
Start Date
2020-09-25
Trial ID
NCT04592419
Treatments Being Tested
A phase 2, multicenter, randomized, active-controlled, masked, parallel arm...
Status
Completed
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02303184
Treatments Being Tested
The purpose of this trial is to evaluate the safety and efficacy of suprach...
Status
Completed
Location
Retinal Consultants of Arizona and Retinal Research Institute
Start Date
2017-07-11
Trial ID
NCT03126786
Treatments Being Tested
This phase II trial studies how well stereotactic body radiation therapy an...
Status
Terminated
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2019-08-09
Trial ID
NCT03712904
Treatments Being Tested
The purpose of the study is to determine the effectiveness of Ranibizumab 0...
Status
Completed
Location
Northern California Retina Vitreous Associates
Start Date
2013-10
Trial ID
NCT01972763
Treatments Being Tested